Overall Technical outlook

Price Summary

Glenmark Pharmaceuticals Limited's stock, on 2026-07-01 opened at 2196.4, climbed to a high of 2221.2, dropped to a low of 2153.1, and closed up -1.57% at 2161.9, with 455256 shares traded.
The stock's highest price over the 52-week span is 2417.9, while the lowest price is 0.0.

Technicals

Support and Resistance: At 2161.9, the price is held up by support at 2136.7 and faces resistance at 2272.7 for GLENMARK. This suggests a trading range where 2136.7 provides a base and 2272.7 limits upward movement.
GLENMARK supportResistance fba7a4
Support/Resistance for GLENMARK


Aroon: The AROON is showing a neutral stance, with no definitive indication of an upward or downward trend for GLENMARK. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
GLENMARK aroon fba7a4
Aroon chart for Glenmark Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
GLENMARK bbands fba7a4
Bolinger Bands chart for Glenmark Pharmaceuticals Limited


Parabolic SAR: The PSAR maintains its bullish stance, setting a significant support level that could help sustain the market's upward movement. This strong support suggests that Glenmark Pharmaceuticals Limited is likely to continue trending higher, providing investors with confidence in the ongoing bullish momentum.
GLENMARK psar fba7a4
Parabolic Stop and Reverse chart for Glenmark Pharmaceuticals Limited


Stochastic: The STOCHASTIC is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
GLENMARK stoch fba7a4
Stochastic chart for Glenmark Pharmaceuticals Limited


Tripple Moving Agerage: The Tripple MOVING AVG is showing a neutral stance, with no definitive indication of an upward or downward trend for GLENMARK. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
GLENMARK trippleSMA fba7a4
Tripple SMA chart for Glenmark Pharmaceuticals Limited


Before focusing on technical indicators like stock price and volume, it's important to consider a company's fundamentals. These include financial metrics such as profitability, revenue growth, and debt levels. Furthermore, understanding the industry landscape, including competition and consumer trends, provides essential context. By combining this fundamental analysis with technical data, investors can make more informed decisions and draw deeper conclusions about the company's potential for future growth and success.